Diorg9K Life Science Profile
Key Indicators
- Authorised Capital ₹ 25.00 K
- Paid Up Capital ₹ 25.00 K
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Diorg9K Life Science
Diorg9k Life Science Private Limited (DLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 August 2020 (Four years and five months 25 days old ). Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 K and a paid-up capital of Rs 25.00 K , as per Ministry of Corporate Affairs (MCA) records.
Alok Kumar and Pawan Kumar serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100UP2020PTC133185
-
Company No.
133185
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Aug 2020
-
Date of AGM
30 Nov 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Diorg9k Life Science Private Limited offer?
Diorg9K Life Science Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Juice, Ayurvedic,Herbal Products & Medicine, Ayurvedic,Herbal Drops & Concentrates.
Who are the key members and board of directors at Diorg9K Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Kumar
|
Director | 07-May-2022 | Current |
|
Alok Kumar
|
Director | 22-Aug-2023 | Current |
Financial Performance of Diorg9K Life Science.
Enhance accessibility to Diorg9K Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diorg9K Life Science?
Unlock access to Diorg9K Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diorg9K Life Science?
Diorg9K Life Science has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diorg9K Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diorg9K Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
